Answers are grounded in this paper and cite their sources.
Mucosal melanoma (MM) is a rare, aggressive subtype of melanoma that arises from the uncontrolled proliferation of melanocytes located within mucous membranes. To date, the immune cell composition in the tumor microenvironment (TME) of MM remains largely unexplored. Gaining a deeper understanding of this immune infiltrate is of importance to understand the poorer response to immune checkpoint inhibitors (ICI) of patients with metastatic MM compared to cutaneous melanoma (CM). This knowledge may help optimize the use of current treatment options and the development of new strategies to target MM. In this explorative study of retrospective nature, we performed multiplex immunohistochemistry (mIHC) to visualize the presence of tumor-infiltrating lymphocytes (TILs) and dendritic cell (DC) subsets in situ in the TME of archival primary MM (pMM) tissues (head and neck MM: n = 8, gynaecological MM: n = 12, gastrointestinal MM: n = 4) from 24 patients. Multispectral imaging was performed, and images were analyzed using the in-house developed machine learning algorithm ImmuNet. A highly variable infiltration of DCs and TILs was seen in the tumor and invasive margin between tumors from different patients. B cell infiltration in the tumor was significantly higher in pMMs originating in the gastrointestinal tract, compared to head and neck pMMs. The mean ranks of B cell density (χ 2 (2) = 10.617, p = 0.005), NK cell density (χ 2 (2) = 13.095, p = 0.001), and regulatory T cell (Treg) density (χ 2 (2) = 21.988, p < 0.001) were found to be statistically significant between melanoma subtypes, with pMM tending to have higher values for B cell and NK cell density compared to primary CM (pCM) and primary uveal melanoma (pUM), and higher values for regulatory T cell density compared to pUM. Patients with a pMM have highly variable infiltration of different immune cell subsets in the TME that can be detected in situ using mIHC. Densities differed between pMM and pCM and pUM. However, no differences in immune cell densities were found between ICI responders and non-responders in the advanced setting, and density of individual immune cell subsets were not shown to be associated with overall survival in this study.
No takes yet. Share an insight, caveat, or question.
Wandeloo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: